GranuFlo Lawsuits Mount in Federal Litigation, as Filings Surpass 2,000, Bernstein Liebhard LLP Reports

The Firm is actively filing GranuFlo lawsuits on behalf of dialysis patients who suffered heart attacks, strokes, and other catastrophic cardiovascular events allegedly due to the use of GranuFlo and NaturaLyte dialysis concentrates.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Free Case Review
Our Firm continues to hear from individuals who were allegedly harmed by GranuFlo and NaturaLyte. We are not surprised that this proceeding continues to grow.

New York, New York (PRWEB) August 23, 2014

GranuFlo lawsuit (http://www.thegranuflolawsuit.com) filings stemming from the 2012 GranuFlo and NaturaLyte dialysis concentrate recall continue to mount in a federal multidistrict litigation underway in U.S. District Court, District of Massachusetts, Bernstein Liebhard LLP reports. According to an updated docket report issued by the U.S. Judicial Panel on Multidistrict Litigation (JPML) on August 15th, at least 2,028 claims are pending in the proceeding. In July, the Panel reported that 1,942 GranuFlo and NaturaLyte lawsuits had been filed, indicating that 96 cases have been added to the litigation over the past month. (In re Fresenius GranuFlo/Naturalyte Dialysate Litigation, MDL No. 2428)

“Our Firm continues to hear from individuals who were allegedly harmed by GranuFlo and NaturaLyte. We are not surprised that this proceeding continues to grow,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now offering free and confidential GranuFlo lawsuit evaluations to individuals who allegedly suffered serious heart injuries after being administered the dialysis drugs.

GranuFlo and NaturaLyte Lawsuit Allegations:
According to court documents, all of the claims pending in the District of Massachusetts were filed on behalf of individuals who allegedly suffered catastrophic cardiovascular events, including heart attacks, strokes, and sudden cardiac death, due to the administration of GranuFlo and NaturaLyte during dialysis treatments. The lawsuits also accuse Fresenius Medical Care of failing to adequately warn dialysis patients and their doctors about the heart injuries related to the use of its products, and assert that the company continued to promote the dialysis concentrates even after becoming aware of their potential risks.

On March 29, 2012, Fresenius issued an Urgent Product Notification that warned of GranuFlo and NaturaLyte’s association with metabolic alkalosis, a condition that may be associated with serious heart problems. According to the notice, the two products contained a higher level of an ingredient the body converts to bicarbonate, and needed to be dosed differently than rival dialysis concentrates. Two months later, the U.S. Food & Drug Administration (FDA) granted the notification Class I recall status, its most urgent safety alert.

A New York Times report published in June 2012 indicates that the FDA was also investigating Fresenius Medical Care, after finding that the company knew about hundreds of patient deaths that followed use of GranuFlo and NaturaLyte.*

Individuals who allegedly suffered heart attacks, strokes, or other life-threatening heart events within 72 hours of using GranuFlo and NaturaLyte in dialysis may be entitled to compensation for their injuries. Learn more about lawsuits filed after the GranuFlo recall at Bernstein Liebhard LLP’s website, or the Firm’s Facebook page: https://www.facebook.com/granuflolawsuit. For additional information, and to arrange for a free case review, please call 800-511-5092.

*nytimes.com/2012/06/15/health/fda-investigates-fresenius-for-failure-to-warn-of-risk.html; New York Times, June 14, 2012

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.thegranuflolawsuit.com
https://plus.google.com/115936073311125306742?rel=author